ACTRN12619001712190招募中4 期
A trial of ivermectin-based mass drug administration (MDA) for scabies in northern India
The Nossal Institute for Global Health (University of Melbourne)0 个研究点目标入组 2,200 人开始时间: 2019年12月5日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 2,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •All residents of the study area are eligible to participate in this study
排除标准
- •As this is a mass drug administration program, all residents of the selected area are eligible for inclusion in this study. However, the exclusion criteria for drug administration are:
- •- Allergy to any of the components of the allocated drug regimen
- •- Currently on or has taken ivermectin in the previous 7 days
- •- Clinical diagnosis of crusted scabies (will be referred for specialist assessment)
- •These criteria exclude individuals from study drug administration but they remain eligible for inclusion in the study.
研究者
相似试验
进行中（未招募）
1 期
Study of the efficacy of ivermectin in the treatment and prevention of COVID-19EUCTR2020-001994-66-ESFundació Assistencial Mútua Terrassa266
尚未招募
3 期
Repeat Ivermectin Mass Drug Administrations for MALaria Control II (RIMDAMAL II)MalariaPACTR201907479787308Colorado State University4,700
已完成
4 期
Clinical trial with ivermectine for the treatment of Mansonella ozzardi infectionsMansoneliasis caused by Mansonella ozzardiPublic Health - EpidemiologyACTRN12609000005257niversity of Sao Paulo80
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation
已完成
4 期
Ivermectin Mass Drug AdministratiomalariatransmissionivermectinTCTR20210219009Mahidol University6,356